DEPOCON Side Effects

5823716-9 | Injection Site Movement Impairment, Injection Site Necrosis, Injection Site Pain, Paraesthesia, Pruritus
on Jul 15, 2008 Female patient from AUSTRIA , 52 years of age, was diagnosed with contraception and was treated with Depocon (View Usage). Patient experienced the following unwanted or unexpected effects: injection site movement impairment, injection site necrosis, injection site pain, paraesthesia, pruritus. Depocon dosage: . Patient was hospitalized.

5812311-3 | Injection Site Movement Impairment, Injection Site Necrosis, Injection Site Pain, Paraesthesia, Pruritus
Patient was taking Depocon (View Usage). Patient had the following side effects: injection site movement impairment, injection site necrosis, injection site pain, paraesthesia, pruritus on Jul 04, 2008 from AUSTRIA Additional patient health information: Female patient , 52 years of age, was diagnosed with contraception and. Depocon dosage: . Patient was hospitalized.

5802055-6 | Injection Site Movement Impairment, Injection Site Necrosis, Injection Site Pain, Paraesthesia, Pruritus
Adverse event was reported on Jun 26, 2008 by a Female patient taking Depocon (View Usage) (Dosage: ) was diagnosed with contraception and. Location: AUSTRIA , 52 years of age, After Depocon was administered, patient had the following side effects: injection site movement impairment, injection site necrosis, injection site pain, paraesthesia, pruritus. Patient was hospitalized.

5701118-3 | Chlamydial Infection, Unintended Pregnancy
on Apr 01, 2008 Female patient from AUSTRIA , weighting 127.9 lb, was diagnosed with contraception and was treated with Depocon (View Usage). Patient experienced the following unwanted or unexpected effects: chlamydial infection, unintended pregnancy. Depocon dosage: .


5484536-0 | Anogenital Warts, Unintended Pregnancy, Uterine Contractions During Pregnancy
on Oct 03, 2007 Female patient from AUSTRIA , weighting 135.6 lb, was diagnosed with contraception and was treated with Depocon (View Usage). Patient had the following side effects: anogenital warts, unintended pregnancy, uterine contractions during pregnancy. Depocon dosage: . Patient was hospitalized.

5420066-X | Deep Vein Thrombosis, Pulmonary Embolism
Patient was taking Depocon (View Usage). After Depocon was administered, patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?), pulmonary embolism (What is pulmonary embolism?) on Aug 08, 2007 from AUSTRIA Additional patient health information: Female patient , 47 years of age, was diagnosed with contraception and. Depocon dosage: .

5397123-X | Injection Site Necrosis
Adverse event was reported on Jul 16, 2007 by a Female patient taking Depocon (View Usage) (Dosage: ) was diagnosed with contraception and. Location: AUSTRIA , 39 years of age, weighting 149.9 lb, Patient experienced the following unwanted or unexpected effects: injection site necrosis. During the same period patient was treated with HALCION (View Halcion Review and Halcion Label ), XANOR (View Xanor Review and Xanor Label ), CIPRALEX (View Cipralex Review and Cipralex Label ), SEROQUEL (View Seroquel Review and Seroquel Label ).

5384595-X | Injection Site Necrosis
on Jul 03, 2007 Female patient from AUSTRIA , 39 years of age, weighting 149.9 lb, was diagnosed with contraception and was treated with Depocon (View Usage). Patient had the following side effects: injection site necrosis. Depocon dosage: .

5366594-7 | Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Cytomegalovirus Infection, Pulmonary Embolism
on Jun 13, 2007 Female patient from AUSTRIA , 27 years of age, was diagnosed with contraception and was treated with Depocon (View Usage). After Depocon was administered, patient had the following side effects: chronic inflammatory demyelinating polyradiculoneuropathy, cytomegalovirus infection (What is cytomegalovirus infection?), pulmonary embolism (What is pulmonary embolism?). Depocon dosage: .

5245563-1 | Hypertension, Weight Increased
Patient was taking Depocon (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, weight increased on Feb 13, 2007 from AUSTRIA Additional patient health information: Female patient , weighting 176.4 lb, was diagnosed with contraception and. Depocon dosage: . During the same period patient was treated with CONCOR (View Concor Review and Concor Label ), VALSARTAN AND HYDROCHLOROTHIAZIDE (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), COLOFAC (View Colofac Review and Colofac Label ).